Insider Activity Update: David Schmidt Executes Options Exercise, Resulting In $431K At Astrana Health

Disclosed in a recent SEC filing on January 15, Schmidt, Director at Astrana Health (NASDAQ:ASTH), made a noteworthy transaction involving the exercise of company stock options. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Schmidt, Director at Astrana Health, a company in the Health Care sector, just exercised stock options worth 20,000 shares of ASTH stock with an exercise price of $5.79. During Friday's morning session, Astrana Health shares down by 0.0%, currently priced at $27.38. Considering the current price, Schmidt's 20,000 shares have a total value of $431,800. Unveiling the Story Behind Astrana Health Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment. Key Indicators: Astrana Health's Financial Health Revenue Growth: Over the 3 months period, Astrana Health showcased positive performance, achieving a revenue growth rate of 99.71% as of 30 September, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector. Key Insights into Profitability Metrics: Gross Margin: The company issues a cost efficiency warning with a low gross margin of 10.17%, indicating potential difficulties in maintaining profitability compared to its peers. Earnings per Share (EPS): Astrana Health's EPS reflects a decline, falling below the industry average with a current EPS of 0.01. Debt Management: Astrana Health's debt-to-equity ratio is below the industry average at 1.4, reflecting a lower dependency on debt financing and a more conservative financial approach. Assessing Valuation Metrics: Price to Earnings (P/E) Ratio: Astrana Health's current Price to Earnings (P/E) ratio of 144.11 is higher than the industry average, indicating that the stock may be overvalued according to market sentiment. Price to Sales (P/S) Ratio: The current P/S ratio of 0.46 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance. EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): Indicated by a lower-than-industry-average EV/EBITDA ratio of 18.46, the company suggests a potential undervaluation, which might be advantageous for value-focused investors. Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale. The Relevance of Insider Transactions Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction. The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise. However, insider sells may not always signal a bearish view and can be influenced by various factors. Transaction Codes To Focus On When it comes to transactions, investors tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S indicates a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company. Check Out The Full List Of Astrana Health's Insider Trades. This article was generated by Benzinga's automated content engine and reviewed by an editor.